Research programme: T1/ST2 inhibitors - Millennium Pharmaceuticals
Alternative Names: T1/ST2 inhibitors research programme - Millennium PharmaceuticalsLatest Information Update: 23 Aug 2002
At a glance
- Originator Millennium Pharmaceuticals
- Class Small molecules
- Mechanism of Action Interleukin 1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Asthma
Most Recent Events
- 10 Mar 2000 New profile
- 10 Mar 2000 Preclinical development for Asthma in USA (Unknown route)